Michael Schiff
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 112
- Systemic Lupus Erythematosus Research 48
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research 52
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 49
- Immunology top 0.5%
- Plant Science top 0.2%
- Plant Virus Research Studies 10
-
- Lymphoma Diagnosis and Treatment 38
-
- Monoclonal and Polyclonal Antibodies Research 16
-
- Peripheral Neuropathies and Disorders 9
- Co-authors
- Yule LiuSavithramma P. Dinesh‐KumarRoy FleischmannLarry W. MorelandEdward KeystoneArthur L. WeaverDésirée van der HeijdeMark C. Genovese
- Cited by
- RheumatologyHematologyGenetics
- Journals
- Annals of the Rheumatic Diseases (38 papers)The Journal of Rheumatology (9 papers)Current Medical Research and Opinion (6 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Michael Schiff
158 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Rheumatology 11.1k
- Hematology 5.2k
- Genetics 2.3k
- Immunology 3.8k
- Plant Science 4.3k
Countries citing papers authored by Michael Schiff
This map shows the geographic impact of Michael Schiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schiff more than expected).
Fields of papers citing papers by Michael Schiff
This network shows the impact of papers produced by Michael Schiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schiff. The network helps show where Michael Schiff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Schiff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 12 | |
| 2 | 2019 | 16 | |
| 3 | 2019 | 11 | |
| 4 | 2013 | 0 | |
| 5 | Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study | 2013 | 1 |
| 6 | 2012 | 52 | |
| 7 | SAFETY UPDATE ON CERTOLIZUMAB PEGOL (CZP) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) | 2010 | 5 |
| 8 | The Efficacy of Certolizumab Pegol Added to Methotrexate is Sustained Over 2 Years in the Treatment of Rheumatoid Arthritis | 2010 | 8 |
| 9 | 2009 | 24 | |
| 10 | 2008 | 58 | |
| 11 | Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS. | 2006 | 4 |
| 12 | 2006 | 342 | |
| 13 | Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibitionbreakdown → | 2005 | 920 |
| 14 | Autophagy Regulates Programmed Cell Death during the Plant Innate Immune Responsebreakdown → | 2005 | 698 |
| 15 | A simplified disease activity index for rheumatoid arthritis for use in clinical practicebreakdown → | 2003 | 795 |
| 16 | 2003 | 74 | |
| 17 | 2002 | 111 | |
| 18 | Cyclosporine A in rheumatoid arthritis: randomized, placebo controlled dose finding study. | 1999 | 12 |
| 19 | 1996 | 84 | |
| 20 | Impairments and writeoffs of long-lived assets | 1989 | 5 |
About Michael Schiff
Michael Schiff is a scholar working on Rheumatology, Hematology and Genetics, having authored 164 papers that have together received 19.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (112 papers), Autoimmune and Inflammatory Disorders Research (52 papers), Chronic Lymphocytic Leukemia Research (49 papers), Systemic Lupus Erythematosus Research (48 papers), Lymphoma Diagnosis and Treatment (38 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Plant Virus Research Studies (10 papers) and Peripheral Neuropathies and Disorders (9 papers). The work is most often cited by research in Rheumatology (11.1k citations), Hematology (5.2k citations) and Genetics (2.3k citations). Michael Schiff has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Yule Liu, Savithramma P. Dinesh‐Kumar, Roy Fleischmann, Larry W. Moreland, Edward Keystone, Arthur L. Weaver, Désirée van der Heijde, Mark C. Genovese, Joan M. Bathon and Rajendra Marathe. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Current Medical Research and Opinion, Arthritis Research & Therapy and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.